The government presents an action plan to standardize AYUSH products and their manufacturing process: Sonowal


Read the article

The government has formulated an action plan to standardize Ayurvedic Medicines, Siddha, Unani and Homeopathy (ASU & H) in the country, and established the Pharmacopoeia Commission for Indian Medicine and Homeopathy (PCIM & H) under the ministry of AYUSH, Sarbananda Sonowal, Minister of AYUSH, told Rajya Sabha.

He also said that the main mandate of the commission is to publish and review Ayurvedic Pharmacopoeia of India (API), Siddha Pharmacopoeia of India (SPI), Unani Pharmacopoeia of India (UPI) and the Homeopathic Pharmacopoeia of India (HPI). Pharmacopoeia standards aim to ensure the quality, safety and efficacy of Ayurvedic, Siddhas, Unani and homeopathic medicines. The Pharmacopoeia Commission is also responsible for publishing and revising official Ayurvedic, Siddhas and Unani forms and statutory collections. These published standards are part of the Medicines and Cosmetics Act, 1940 and The Rules, 1945 for verifying the quality standards of raw materials / medicines, and implemented uniformly throughout India.

It is mandatory for the drug manufacturer ASU & H to obtain a license from the relevant National Licensing Authority (SLA) and comply with Good Manufacturing Practices (GMP) and drug quality standards prescribed in pharmacopoeias. respective. The SLA grants the license after verification of the required infrastructure, equipment / machines, manpower of the manufacturing unit through the inspections carried out by the inspector. The government has also established separate central research councils to undertake, promote and coordinate research and scientific validation of Ayurvedic, unani, siddha and homeopathic medicines, Sonowal added.

The Minister added that so far the government has released Ayurvedic Form of India (Part I-III) containing 986 formulations, Siddha Form of India (Part I-II) containing 400 formulations and Form National Medicine Unani (Vol. I-VI) containing 1,230 formulations. Monographs of the quality standards of 645 unique medicines and 203 Ayurveda formulations; 139 unique drugs and a formulation of Siddha; 298 unique drugs and 201 formulations of Unani; and 1,117 homeopathic medicines (Vol. IX).

The Central Council for Research in Homeopathy (CCRH) has filed eight patents and the Central Council for Research in Ayurvedic Sciences (CCRAS) has obtained a patent, the Central Council for Research in Siddha (CCRS) has filed a patent for 10 products during of the past five years, he concluded.


Comments are closed.